ADA Scientific Sessions 2026 Abstract
Novel Oral Brain Penetrant NLRP3 Inhibitor PSTC2501 for Treatment of Obesity and Cardiovascular Diseases
Experiments in animalsInterventions
Papers by Zhouchong Wang
2 results
- ADA Scientific Sessions 2026 Abstract
First Disclosure of PSTC1411, a Novel Oral G-Protein-Biased Apelin Agonist Demonstrating Monotherapy Efficacy for Weight Loss and Muscle Preservation
Experiments in animalsInterventions